期刊
EXPERIMENTAL GERONTOLOGY
卷 152, 期 -, 页码 -出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.exger.2021.111438
关键词
Curcumin; Carcinogenesis; Pharmacokinetics; Pharmacodynamics; In vitro; In vivo; Clinical studies
Colorectal cancer ranks as the third deadliest cancer worldwide, with conventional treatment methods often facing issues like multidrug resistance and side effects. Physicians and scientists are collaborating to explore the use of curcumin for new treatment approaches, including chemotherapy and chemosensitization.
Cancer is one of the life-taking diseases worldwide and among cancer-related death; colorectal cancer is the third most. Though conventional methods of treatment are available, multidrug resistance and side effects are predominant. Physicians and scientists are working side by side to develop an effective medicament, which is safe and cost-effective. However, most failures are obtained when focused on the clinical perspective. This review mainly brings out the correlation between the curcumin and its use for the mitigation of colorectal cancer, the use of curcumin as a chemotherapeutic agent, chemosensitizer, and in a combination and synergistic approach. The pharmacokinetics and pharmacodynamics properties of curcumin and its formulation approach helps in giving an idea to develop new approaches for the treatment of colorectal cancer using curcumin.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据